Tower Research Capital (TRC)’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.27K | Sell |
1,155
-11,587
| -91% | -$62.9K | ﹤0.01% | 4116 |
|
2025
Q1 | $35.5K | Buy |
12,742
+6,963
| +120% | +$19.4K | ﹤0.01% | 2483 |
|
2024
Q4 | $19.7K | Buy |
5,779
+9
| +0.2% | +$31 | ﹤0.01% | 3195 |
|
2024
Q3 | $17K | Sell |
5,770
-245
| -4% | -$720 | ﹤0.01% | 3340 |
|
2024
Q2 | $20.5K | Buy |
6,015
+2,436
| +68% | +$8.28K | ﹤0.01% | 3754 |
|
2024
Q1 | $10.8K | Buy |
3,579
+111
| +3% | +$336 | ﹤0.01% | 3638 |
|
2023
Q4 | $14.6K | Sell |
3,468
-2,122
| -38% | -$8.93K | ﹤0.01% | 3877 |
|
2023
Q3 | $38.2K | Sell |
5,590
-3,346
| -37% | -$22.9K | ﹤0.01% | 2795 |
|
2023
Q2 | $93.1K | Buy |
8,936
+7,402
| +483% | +$77.1K | ﹤0.01% | 2057 |
|
2023
Q1 | $11K | Sell |
1,534
-4,674
| -75% | -$33.5K | ﹤0.01% | 4198 |
|
2022
Q4 | $37K | Buy |
6,208
+4,589
| +283% | +$27.4K | ﹤0.01% | 2558 |
|
2022
Q3 | $13K | Sell |
1,619
-2,211
| -58% | -$17.8K | ﹤0.01% | 4261 |
|
2022
Q2 | $52K | Buy |
3,830
+2,714
| +243% | +$36.8K | ﹤0.01% | 2836 |
|
2022
Q1 | $21K | Sell |
1,116
-2,415
| -68% | -$45.4K | ﹤0.01% | 3479 |
|
2021
Q4 | $121K | Buy |
3,531
+3,253
| +1,170% | +$111K | ﹤0.01% | 2107 |
|
2021
Q3 | $15K | Sell |
278
-7,448
| -96% | -$402K | ﹤0.01% | 3966 |
|
2021
Q2 | $567K | Buy |
+7,726
| New | +$567K | 0.01% | 1082 |
|